top
Search terms
Results 1 - 10 of 25 - ordered by :
Pages: 1 2 3
Ehjcvp

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Lars Wallentin, Stefan K. James, Tomas Jernberg

Date : 01/01/2016 Item size : 280123 bytes
Ehjcvp

In this issue of European Heart Journal: Cardiovascular Pharmacology, Johnson et al. report an observational study on the relationship between conventional risk factors and the incidence of AF in ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Farhan Shahid, Eduard Shantsila, Gregory Y. H. Lip

Date : 01/04/2016 Item size : 149125 bytes
Ehjcvp

Abstract Aims An important decision in the management of patients with atrial fibrillation is whether to adopt a rate or rhythm control strategy. Methods and results We conducted a retrospective ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Carl Hayward, Hitesh C. Patel, Ketna Patel, Carlo Di Mario, Alexander R. Lyon, Syed Y. Ahsan, Edward Rowland

Date : 01/04/2016 Item size : 222623 bytes
Ehjcvp

Vice versa, patients presenting with acute coronary syndromes (ACS) develop AF in 621% of cases, hence, through the presence of vascular disease, these patients automatically require anticoagulation ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Miklos Rohla, Thomas W. Weiss, Johann Wojta, Alexander Niessner, Kurt Huber

Date : 01/07/2015 Item size : 293945 bytes
Ehjcvp

Abstract Aims We compared clinical outcomes in patients with AF with and without diabetes in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lopes, Daniel M. Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. ...

Date : 01/04/2015 Item size : 304584 bytes
Ehjcvp

Recent data from seven European countries show a much better adherence to evidence and recommendations for oral anticoagulation.1 Interestingly, NOACs were given to younger patients and only to 6% of ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Rocio Hinojar, Jose Julio Jiménez-Natcher, Covadonga Fernández-Golfín, Jose Luis Zamorano

Date : 01/04/2015 Item size : 312462 bytes
Ehjcvp

Oral anticoagulation (OAC) is recommended for patients with atrial fibrillation (AF) who are at risk of stroke.1 The CHA2DS2-VASc score, which encompassed a group of common co-morbidities for ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Jo Jo Hai, Hung-Fat Tse

Date : 01/04/2015 Item size : 156814 bytes
Ehjcvp

Atrial fibrillationIschaemic strokePreventionOral anticoagulationIntroduction Atrial fibrillation (AF) is an expanding epidemic,1 and ischaemic stroke due to cardioembolism remains a trademark ...

European Heart Journal - Cardiovascular Pharmacotherapy, Current Opinion, Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y. H. Lip

Date : 12/08/2016 Item size : 256208 bytes
Ehjcvp

MagnesiumArrhythmiaCardiovascular diseaseIntroduction Magnesium is the fourth most abundant cation in the human body and is the second most prevalent cation in intracellular tissues.1 Its primary ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, William L. Baker

Date : 15/09/2016 Item size : 510171 bytes
Ehjcvp

The EMPA-REG outcome trial showed improved survival and less hospitalization for HF: it is changing concepts and practice.1 The new era of outcome trials follows the acute awareness of the need to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Basil S. Lewis

Date : 01/10/2016 Item size : 203582 bytes